Status:
COMPLETED
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Institut de Recherche pour le Developpement, Senegal
Cheikh Anta Diop University, Senegal
Conditions:
Malaria
Eligibility:
All Genders
1-5 years
Phase:
PHASE3
Brief Summary
A recent study has shown that the administration of a single dose of sulfadoxine/pyrimethamine plus artesunate to Senegalese children on three occasions during a short malaria transmission season redu...
Detailed Description
Background: In countries of the Sahel and sub-Sahel, malaria transmission is highly seasonal with nearly all episodes of malaria occuring during a few months of the year. However, mortality and morbi...
Eligibility Criteria
Inclusion
- Ages 1 - 5 years
- Residence in the study area
- Informed consent
Exclusion
- Known allergy to study drugs
- Chronic, underlying illness
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT00132548
Start Date
June 1 2004
End Date
December 1 2004
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de recherche pour le developpement
Dakar, Senegal, BP 1386